These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24927508)

  • 21. A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs.
    Shi QP; He XD; Yu ML; Zhu JX; Liu Y; Ding F; Sang R; Jiang XD; Zhang SQ
    Int J Clin Pharmacol Ther; 2014 May; 52(5):392-401. PubMed ID: 24691061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug makers' adverse event reports are often incomplete, US report finds.
    McCarthy M
    BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adverse events related to substitution of generic products in Norway 2005].
    Reppe LA; Stenberg-Nilsen H; Harg P; Hegge AB; Lillefloth AK; Buajordet I
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2696-700. PubMed ID: 19079413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy.
    Juhlin K; Ye X; Star K; Norén GN
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1119-29. PubMed ID: 23832706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Spontaneous reporting system data analysis of parenterally administered Shenmai].
    Wang LX; Xiang YY; Xie YM; Shen H; Ai QH
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2987-93. PubMed ID: 24471317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
    Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
    BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is inappropriate medication use a major cause of adverse drug reactions in the elderly?
    Laroche ML; Charmes JP; Nouaille Y; Picard N; Merle L
    Br J Clin Pharmacol; 2007 Feb; 63(2):177-86. PubMed ID: 17166186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study.
    Hedna K; Hägg S; Andersson Sundell K; Petzold M; Hakkarainen KM
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1317-25. PubMed ID: 24127242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
    Jiang JJ; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A general practitioner's one year record of adverse drug reactions].
    Grange JC
    Therapie; 2012; 67(3):237-42. PubMed ID: 22874490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor.
    Wallerstedt SM; Brunlöf G; Johansson ML; Tukukino C; Ny L
    Eur J Clin Pharmacol; 2007 May; 63(5):505-8. PubMed ID: 17347804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL; Oger J
    Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
    Makus KG; McCormick J
    Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse Drug Reactions in Canada (2009-2018): Insights from the Canada Vigilance Database.
    Maity TS; Longo CJ
    Healthc Q; 2020 Apr; 23(1):40-46. PubMed ID: 32249738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.